Wed, Sep 14|
Ask the Expert: Her2 low with Dr. Paolo Tarantino.
Come and learn about the new evolving research on HER 2 low. Bring your caregivers and questions.
Time & Location
Sep 14, 2022, 5:00 PM – 6:00 PM EDT
About the Event
HER2 has been determined and categorized in the past 2 decades, what has happened in the last 2 years that made us formulate this new intermediate category of "HER2-low" tumors, the data that finally confirmed this year that HER2-low is here to stay (DESTINY-Breast04 trial), how to best use this new treatment option for the treatment of HR+ MBC and TNBC, the main challenges that we're facing in this new HER2-low era, and finally how I expect the definition of HER2-low to evolve in the coming years.
Join Dr. Paolo Tarantino from Dana Farber, an expert on Her2.